Rigel Pharmaceuticals (RIGL) Profit After Tax (QoQ) (2010 - 2026)
Rigel Pharmaceuticals (RIGL) Profit After Tax (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - |
| 10 | Rigel Pharmaceuticals | 702.42 Mn | 555.73 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.77% |
| Dec 31, 2025 | 860.81% |
| Sep 30, 2025 | -53.20% |
| Jun 30, 2025 | 420.82% |
| Mar 31, 2025 | -20.19% |
| Dec 31, 2024 | 15.46% |
| Sep 30, 2024 | 1,305.92% |
| Jun 30, 2024 | 87.51% |
| Mar 31, 2024 | -1,219.00% |
| Dec 31, 2023 | 112.95% |
| Sep 30, 2023 | 13.76% |
| Jun 30, 2023 | 51.24% |
| Mar 31, 2023 | -1,066.17% |
| Dec 31, 2022 | 107.36% |
| Sep 30, 2022 | -41.10% |
| Jun 30, 2022 | 50.84% |
| Mar 31, 2022 | -21.22% |
| Dec 31, 2021 | -8.06% |
| Sep 30, 2021 | -51.60% |
| Jun 30, 2021 | -134.99% |